Form 483

Saptalis Pharmaceuticals LLC Form 483, 2026-03-06

FDA issued a Form 483 to Saptalis Pharmaceuticals LLC on 2026-03-06 with 1 public-safe observation.

483· Form 483 issuedHuman Drugs1 observation

Saptalis Pharmaceuticals LLC · Hauppauge, United States · Issued March 6, 2026

Overview

  • 1 public-safe observation is available for this inspection.
  • 1 structured CFR citation is represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

6 Mar 2026
21 CFR 211.63

Equipment Design, Size and Location

Cited by Alice S Tsao, Emmanuel T Donyina

Inspected site

SPSaptalis Pharmaceuticals LLCHauppauge, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.63Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 1 observation

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere